Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NEWPORT BEACH, CA--(Marketwire - Jan 3, 2012) - NVISION Laser Eye Centers CEO Todd Cooper announced today the appointment of Dr. Jimmy K. Lee, MD to provide LASIK and cataract surgery at NVISION...
-
BRISBANE, Calif. and MOUNTAIN VIEW, Calif., Jan. 3, 2012 (GLOBE NEWSWIRE) -- Cutera, Inc. (Nasdaq:CUTR) and IRIDEX Corporation (Nasdaq:IRIX) today announced that the companies have entered into a...
-
ST. LOUIS, Mo., Dec. 13, 2011 (GLOBE NEWSWIRE) -- For the second time in a year, the USDA awarded Mercy a $500,000 telemedicine grant which will ultimately provide greater access to health care in...
-
VANCOUVER, British Columbia, Dec. 8, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) will be hosting a Research and Development Day on Friday, December 16, 2011, starting at 8:30 a.m. EST /...
-
SOUTH SAN FRANCISCO, Calif., Dec. 7, 2011 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases,...
-
BROSSARD, QUEBEC, CANADA--(Marketwire - Nov. 30, 2011) - DIAGNOS inc. ("DIAGNOS" or the "Corporation") (TSX VENTURE:ADK), a leader in the use of knowledge discovery and artificial...
-
Part B of Study With More Potent Formulation Currently Underway EMERYVILLE, Calif., Nov. 30, 2011 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE AMEX:NBY), a clinical-stage...
-
BROSSARD, QUEBEC, CANADA--(Marketwire - Nov. 28, 2011) - DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in the use of artificial intelligence and advanced...
-
Boulder, CO, Nov. 28, 2011 (GLOBE NEWSWIRE) -- Dr. Michael McCracken, a leading plastic surgeon in Colorado, announced today the opening of McCracken Eye and Face Institute’s new Boulder, CO...
-
NVC-422 Called "Effective Alternative to Known Antimicrobial Compounds" EMERYVILLE, Calif., Nov. 14, 2011 (GLOBE NEWSWIRE) -- A monograph on NovaBay's lead Aganocide® NVC-422 was recently...